MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Validation of the XDP-MDSP rating scale for the evaluation of patients with X-linked dystonia-parkinsonism (XDP)

P.D. Pasco, L.V. Lee, R.G. Jamora, C.E. Diesta, A.R. Ng, R.A. Teleg, C.L. Go, R.L. Rosales, H.H. Fernandez (Manila, Philippines)

Meeting: 2016 International Congress

Abstract Number: 1675

Keywords: Scales

Session Information

Date: Thursday, June 23, 2016

Session Title: Dystonia

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To validate the proposed XDP-MDSP (X-linked dystonia-parkinsonism – The Movement Disorder Society of the Philippines) rating scale in patients clinically diagnosed to have XDP.

Background: X-Linked Dystonia Parkinsonism (XDP, DYT3) is an adult-onset, degenerative movement disorder endemic to Panay Island. We developed the XDP-MDSP rating scale to classify patients as to extent and severity of disease, track their progression, and determine response to treatment.

Methods: The proposed scale was administered to patients with a clinical diagnosis of XDP. Each patient was evaluated by one rater. After the XDP-MDSP scale was completed, the following were done by the same examiners to determine construct validity by correlating the different parts of the scale with the following validated scales: Burke-Fahn-Marsden dystonia scale, UPDRS Motor scale, NMSQuest scale, and SCOPA-ADL scale. Divergent validity was determined by correlating the scale with the Hamilton Anxiety and Depression scale and the Mini-Mental Status Exam.

Results: A total of 204 patients were recruited to the study. Cronbach’s alpha for the entire 5-part scale was acceptable at 0.805. Inter-domain correlation for the first four parts of the scale measuring four different domains (dystonia, parkinsonism, non-motor features, and activities of daily living) was acceptable with ranges from 0.434 to 0.671; the correlation between these domains and the last (global rating) was slightly lower at 0.319 to 0.447. Convergent validity was tested by performing Pearson correlation with other scales: Part I and BFM; Part II and UPDRS; Part III and NMS; and Part IV and SCOPA. Correlation was acceptable with values ranging from 0.323 to 0.428. Divergent validity was tested by performing Pearson correlation with three other scales: MMSE, HADS-P, and HAMD. There was significant correlation between the scale and HADS-P and HAMD.

Conclusions: The proposed XDP-MDSP scale is internally valid, although the last domain (global rating) may have to be modified slightly due to lower correlation with the other domains. Since Pearson correlation is acceptable, there is also convergent validity. On the other hand, the significant correlation between the proposed scale and the HADS-P and HAMD may be due to the fact that many patients also have concomitant anxiety and depression. Another scale can perhaps be used to measure divergent validity.

To cite this abstract in AMA style:

P.D. Pasco, L.V. Lee, R.G. Jamora, C.E. Diesta, A.R. Ng, R.A. Teleg, C.L. Go, R.L. Rosales, H.H. Fernandez. Validation of the XDP-MDSP rating scale for the evaluation of patients with X-linked dystonia-parkinsonism (XDP) [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/validation-of-the-xdp-mdsp-rating-scale-for-the-evaluation-of-patients-with-x-linked-dystonia-parkinsonism-xdp/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/validation-of-the-xdp-mdsp-rating-scale-for-the-evaluation-of-patients-with-x-linked-dystonia-parkinsonism-xdp/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley